Renalytix Revenue and Competitors
Estimated Revenue & Valuation
- Renalytix's estimated annual revenue is currently $18.1M per year.
- Renalytix's estimated revenue per employee is $155,000
Employee Data
- Renalytix has 117 Employees.
- Renalytix grew their employee count by 0% last year.
Renalytix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder and CEO | Reveal Email/Phone |
3 | Chief Strategy & Marketing Officer | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Technology Officer | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | Chief Human Resources Officer | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | VP Sales | Reveal Email/Phone |
Renalytix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.2M | 161 | 8% | $1.4B | N/A |
What Is Renalytix?
N/A
Total Funding
117
Number of Employees
$18.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Renalytix News
2022-03-30 - Renalytix announces a $30.0 million financing package
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the global founder and leader in the new field of bioprognosis for kidney health. The company has...
2022-03-30 - Renalytix Reaches Enrollment Milestone for Building ...
Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes.
2022-03-30 - Renalytix Reports Financial Results for Second Quarter of ...
and Renalytix AI Limited (collectively, Renalytix, or the Company) is an artificial intelligence-enabled in vitro diagnostics company...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.1M | 117 | 8% | N/A |
#2 | $29.6M | 117 | 29% | N/A |
#3 | $11.7M | 117 | 16% | N/A |
#4 | $31.6M | 117 | -6% | N/A |
#5 | $21.1M | 117 | 15% | N/A |
